Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,658 | 294 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,112 | 83 | $0 (2024) |
| Lilly USA, LLC | $525.65 | 34 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $449.16 | 29 | $0 (2024) |
| ABBVIE INC. | $324.85 | 18 | $0 (2024) |
| GlaxoSmithKline, LLC. | $301.45 | 20 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $226.85 | 13 | $0 (2024) |
| Abbott Laboratories | $219.46 | 11 | $0 (2023) |
| PFIZER INC. | $167.94 | 9 | $0 (2024) |
| Shire North American Group Inc | $114.45 | 8 | $0 (2019) |
| Radius Health, Inc. | $112.78 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $320.39 | 15 | ABBVIE INC. ($83.96) |
| 2023 | $806.34 | 46 | Novo Nordisk Inc ($231.32) |
| 2022 | $792.21 | 46 | Novo Nordisk Inc ($178.89) |
| 2021 | $389.65 | 22 | AbbVie Inc. ($86.53) |
| 2020 | $378.03 | 23 | Novo Nordisk Inc ($134.25) |
| 2019 | $466.02 | 34 | Novo Nordisk Inc ($136.04) |
| 2018 | $931.71 | 65 | Novo Nordisk Inc ($256.17) |
| 2017 | $573.90 | 43 | AstraZeneca Pharmaceuticals LP ($155.64) |
All Payment Transactions
294 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: VACCINES | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Vaccines | ||||||
| 08/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Inflammation | ||||||
| 07/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.31 | General |
| 06/27/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $16.63 | General |
| Category: ADHD | ||||||
| 06/06/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Vaccines | ||||||
| 05/31/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: IMMUNOLOGY | ||||||
| 05/28/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $32.78 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: VACCINES | ||||||
| 03/20/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Diabetes | ||||||
| 02/01/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: VACCINES | ||||||
| 01/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Diabetes | ||||||
| 12/15/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Respiratory | ||||||
| 12/14/2023 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $20.07 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/07/2023 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Endocrinology | ||||||
| 11/30/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Diabetes | ||||||
| 11/21/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Diabetes Care | ||||||
| 11/21/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.08 | General |
| Category: Diabetes | ||||||
| 10/31/2023 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Endocrinology | ||||||
| 10/27/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Diabetes | ||||||
| 10/25/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Obesity | ||||||
| 10/22/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 2,557 | 3,480 | $494,628 | $126,201 |
| 2022 | 36 | 2,858 | 3,774 | $561,525 | $144,813 |
| 2021 | 42 | 3,526 | 4,553 | $614,467 | $176,600 |
| 2020 | 35 | 2,969 | 3,863 | $526,419 | $137,461 |
All Medicare Procedures & Services
150 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 369 | 650 | $214,500 | $48,777 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 239 | 298 | $66,156 | $15,682 | 23.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 97 | 97 | $34,629 | $12,116 | 35.0% |
| 77067 | Screening mammography | Office | 2023 | 49 | 49 | $15,876 | $6,063 | 38.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 353 | 491 | $4,907 | $4,124 | 84.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 11 | 106 | $16,642 | $3,772 | 22.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 11 | 91 | $17,745 | $3,279 | 18.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 196 | 216 | $11,880 | $2,834 | 23.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 16 | 16 | $8,464 | $2,557 | 30.2% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 49 | 49 | $6,174 | $2,506 | 40.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 212 | 241 | $10,363 | $2,484 | 24.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 20 | $8,920 | $2,407 | 27.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 32 | 32 | $8,352 | $2,272 | 27.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $7,168 | $2,242 | 31.3% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 33 | 33 | $7,260 | $2,126 | 29.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 136 | 205 | $8,200 | $1,952 | 23.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 84 | 117 | $8,073 | $1,911 | 23.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 85 | 99 | $6,039 | $1,313 | 21.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 113 | 141 | $4,935 | $1,169 | 23.7% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 21 | 21 | $2,520 | $828.71 | 32.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 76 | 90 | $2,880 | $677.29 | 23.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 17 | 17 | $2,142 | $621.52 | 29.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 20 | 21 | $2,331 | $609.21 | 26.1% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 30 | 30 | $2,250 | $567.60 | 25.2% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 13 | 13 | $1,560 | $511.55 | 32.8% |
About Dr. John Walker, MD
Dr. John Walker, MD is a Family Medicine healthcare provider based in The Woodlands, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114959301.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Walker, MD has received a total of $4,658 in payments from pharmaceutical and medical device companies, with $320.39 received in 2024. These payments were reported across 294 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($4,658).
As a Medicare-enrolled provider, Walker has provided services to 11,910 Medicare beneficiaries, totaling 15,670 services with total Medicare billing of $585,074. Data is available for 4 years (2020–2023), covering 150 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location The Woodlands, TX
- Active Since 07/07/2006
- Last Updated 05/15/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1114959301
Products in Payments
- Ozempic (Drug) $564.62
- FARXIGA (Drug) $370.84
- JARDIANCE (Drug) $285.59
- TRULICITY (Drug) $173.32
- Rybelsus (Drug) $164.67
- SHINGRIX (Biological) $160.80
- Victoza (Drug) $138.56
- MOUNJARO (Drug) $130.24
- EMGALITY (Drug) $122.81
- PREVNAR 20 (Biological) $109.15
- UBRELVY (Drug) $101.05
- SYNTHROID (Drug) $99.51
- Tresiba (Drug) $99.08
- BREO (Drug) $84.81
- MYDAYIS (Drug) $76.99
- Trulance (Drug) $74.11
- Wegovy (Drug) $64.55
- VRAYLAR (Drug) $59.33
- Tymlos (Drug) $58.81
- TRINTELLIX (Drug) $55.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in The Woodlands
Caroline Fife, M.d, M.D
Family Medicine — Payments: $541,225
Mouhamed El Zufari, Md, MD
Family Medicine — Payments: $9,478
Kathleen Paz, M.d, M.D
Family Medicine — Payments: $8,510
Hilary Butella, Aprn, Fnp-C, APRN, FNP-C
Family Medicine — Payments: $8,174
Christopher Prihoda, Md, MD
Family Medicine — Payments: $7,752
Mrs. Adrienne Blessing, M.d, M.D
Family Medicine — Payments: $7,326